10 min listen
Episode 1: Bioprinting
FromA view on
ratings:
Length:
8 minutes
Released:
Jun 22, 2020
Format:
Podcast episode
Description
Scientists have been printing cells for decades, but with the arrival of 3D bioprinters, getting printed tissue models to behave like living tissue has proved elusive. That is why angiogenesis and vascularization are two holy grails of 3D bioprinting. Allevi is not stopping at Earth-bound breakthroughs. The US company has also secured funding for simultaneous bioprinting experiments on the International Space Station.
Released:
Jun 22, 2020
Format:
Podcast episode
Titles in the series (32)
Episode 3: Mesenchymal stem cells for COVID-19 treatment: Mesoblast CEO Dr. Silviu Itescu speaks to Lonza about the company’s advanced portfolio of anti-inflammatory allogeneic cellular medicines including remestemcel-L, which is currently being evaluated in a U.S. Phase 3 randomized controlled trial for acute ... by A view on